* Dale Chappell reports 33.2 percent stake in Kalobios
Pharmaceuticals inc as of June 30 – SEC filing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
The post BRIEF-Dale Chappell reports 33.2 pct stake in Kalobios Pharmaceuticals appeared first on NASDAQ.